Salute e Benessere
Blood Collection Devices Market worth $13.02 billion by 2030 with 7.4% CAGR | MarketsandMarkets™
the global blood collection devices market is segmented into blood collection tubes, needles & syringes, blood collection systems/monitors, blood bags, and lancets. In 2024, the blood collection tubes segment accounted for the largest share of the blood collection devices market. The strong position of this segment can be attributed to its versatility, as multiple samples can be collected from a single patient using different tubes for various tests. Most blood collection tubes contain additives that either accelerate clotting (clot activators) or prevent it, enabling their use across a wide range of diagnostic applications. Additionally, the growing demand for accurate, reliable, and standardized sample collection in hospitals, diagnostic laboratories, and blood banks further supports the widespread adoption of blood collection tubes.
the blood collection devices market is broadly categorized into two major applications: diagnostic and therapeutic applications. The diagnostic applications segment dominated the market in 2024. This dominance was driven by the increasing prevalence of chronic diseases and the rising number of corporate and personal health check-ups, which have fueled the demand for frequent and reliable blood testing. The need for accurate, timely, and standardized sample collection in hospitals, diagnostic laboratories, and blood banks further reinforced the segment's leading position during the year. Additionally, advancements in diagnostic technologies and the growing emphasis on preventive healthcare are expected to sustain strong demand for blood collection devices in the diagnostic segment. The integration of automated collection systems and enhanced safety features is also contributing to the widespread adoption of these devices.
, North America , comprising the US and Canada , accounted for the largest share of the global blood collection devices market in 2024, followed by Europe . Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders, better healthcare facilities, and the presence of major manufacturers in the region are stimulating the growth of the blood collection devices market in North America .
Prominent players in the market are Fresenius Kabi AG ( Germany ), Becton, Dickinson and Company (US), Terumo BCT, Inc. (US), Grifols, S.A. ( Spain ), Cardinal Health (US), Nipro Medical Corporation ( Japan ), SARSTEDT AG & Co. KG( Germany ), Haemonetics Corporation (US), Greiner Holding AG ( Austria ), and ICU Medical, Inc. (US).
Fresenius Kabi AG is the largest player in the blood collection devices market. The company offers a broad range of blood collection products, especially blood bags. It has maintained its market position by achieving a high level of customer satisfaction and strong brand equity. Over the years, Fresenius has built a robust product portfolio and a reliable distribution network that can reach the majority of its potential market. In recent years, the company has strengthened its leadership in the blood bags and consumables segment, with increasing focus on automation and sustainability initiatives in manufacturing. Fresenius is also actively expanding its footprint in the Asia Pacific and Latin America , where growing healthcare infrastructure and rising blood donation programs are creating new opportunities.
BD is the second-largest player in the global blood collection devices market and offers one of the broadest portfolios, including blood collection tubes, needles, syringes, blood bag sets, and lancets. The company has established itself strongly through its flagship Vacutainer system and is now diversifying into capillary blood collection technologies. In December 2023 , BD received FDA clearance for a fingerstick device that provides laboratory-quality results at the point of care, and its BD MiniDraw system, developed with Babson Diagnostics, is being deployed in US pharmacies to make blood testing more accessible. BD continues to focus on patient comfort, less-invasive sampling methods, and digital health integration, while leveraging its strong presence in North America and Europe to accelerate expansion across high-growth Asia Pacific markets.
Terumo BCT, Inc. is the third-largest company in the market and is recognized for its broad range of blood collection products, particularly its apheresis systems. The company has developed a strong product and technology platform dedicated to blood collection devices, with long-term strategies focused on automation and emerging market penetration. In 2024, Terumo launched the Intercept 10 Platelet System, an advanced plateletpheresis technology that enhances efficiency and safety. The company has also expanded its manufacturing operations in the US and Costa Rica to reinforce supply chain resilience. It is also investing in digital integration platforms for blood management and expanding into cell-based therapies, positioning itself as a technology-driven leader in both mature and emerging markets.
For more information,
Get access to the latest updates on and
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, , and . With a , we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our , which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/blood-collection-devices-market-worth-13-02-billion-by-2030-with-7-4-cagr--marketsandmarkets-302603559.html